Exp Clin Endocrinol Diabetes 2009; 117(8): 373-377
DOI: 10.1055/s-0029-1220763
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Hypertensive Disorders in Normal/Over-weight and Obese Type 2 Diabetic Pregnant Women

A. Colatrella1 , S. Braucci1 , C. Festa1 , P. Bianchi2 , F. Fallucca1 , L. Mattei1 , M. Trappolini1 , A. Napoli1
  • 1Department of Clinical Sciences, S. Andrea Hospital, 2nd Faculty of Medicine, ‘Sapienza’ University of Rome, Rome, Italy
  • 2Department of Gynaecology, Perinatology and Child Health, S. Andrea Hospital, 2nd Faculty of Medicine, ‘Sapienza’ University of Rome, Rome, Italy
Further Information

Publication History

received 20.11.2008 first decision 13.01.2009

accepted 15.04.2009

Publication Date:
17 June 2009 (online)

Abstract

Background: Hypertension is one of the major complications of pregnancy. Its impact in type 2 diabetic pregnant women could be understimated because it is generally evaluated by retrospective studies and as one of the outcome measures.

Objective: Our aims were: 1) to evaluate the prevalence of hypertensive disease between type 2 diabetic and normal pregnancies; 2) to relate hypertensive disease to body weight in type 2 diabetic pregnancies; 3) to assess the impact of different types of hypertension on pregnancy outcome in type 2 diabetic women.

Study Design: Seventy-six type 2 diabetic (23 normal-weight, 26 overweight and 27 obese) and sixty normal (43, 15 and 2 respectively; x2 0.0001) pregnancies, matched for age and smoking habit. Hypertension was defined as ≥140/90 mmHg and classified in chronic, gestational and pre-eclampsia.

Statistical Analysis: Student's t-test, χ2, simple, and/or multiple and logistic regression analysis were used when appropriate. Odds ratio was calculated for hypertension. p significant <0.05.

Results: The overall prevalence of hypertension was 40.8% (18.4% chronic, 17.1% gestational and 5.3% pre-eclampsia) in type 2 diabetic pregnancies and 10% (8.3% gestational and 1.7% pre-eclampsia) in normal pregnancies (p<0.0001), with an odds ratio of 6.2. All the types of hypertension, significantly chronic, contributed to the higher prevalence. Only in diabetic pregnancies, hypertension was associated with a higher pregestational BMI; whenever BMI increased, chronic and gestational hypertension increased by contrast of pre-eclampsia (χ2, 0.02). Hypertensive disorders did not affect maternal-fetal outcome.

Conclusions: The prevalence of hypertension was 40.8% in type 2 diabetic pregnant women whilst it was 10.0% in non diabetic controls. All hypertensive disorders, significantly chronic, were more frequent. Increasing BMI was a crucial factor for chronic and gestational but not for pre-eclampsia. Hypertensive diseases did not seem to affect pregnancy outcome.

References

  • 1 Feig DS, Palda VA. Type 2 diabetes in pregnancy: a growing concern.  Lancet. 2002;  359 1690-1692
  • 2 Leahy JL. Pathogenesis of type 2 diabetes mellitus.  Arch Med Res. 2005;  36 197-209
  • 3 Solomon CG, Seely EW. Hypertension in pregnancy. A manifestation of the insulin resistance syndrome?.  Hypertension. 2001;  37 232-239
  • 4 Sibai B. et al . Pre-eclampsia.  Seminar. 2005;  365 785-799
  • 5 Hauner H. et al . Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German Primary Care: Data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).  Experimental and Clinical Endocrinology & Diabetes. 2008;  116 ((1)) 18-25
  • 6 Hadden DR. et al . Poor pregnancy outcome for women with type 2 diabetes.  Diabetic Medicine. 2003;  20 505-509
  • 7 Dunne F. et al . Pregnancy in women with type 2 diabetes: 12 years outcome data 1990–2002.  Diabetic Medicine. 2003;  20 734-738
  • 8 Clausen TD. et al . Poor pregnancy outcome in women with type 2 diabetes.  Diabetes Care. 2005;  28 323-328
  • 9 Isermann B. et al . Autoantibodies in Diabetes Mellitus: Current Utility and Perspectives.  Experimental and Clinical Endocrinology & Diabetes. 2007;  115 ((8)) 483-490
  • 10 Weires MB. et al . Familiality of Diabetes Mellitus.  Experimental and Clinical Endocrinology & Diabetes. 2007;  115 ((10)) 634-640
  • 11 Metzger BE, Coustan DR. The organizing Committee: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus.  Diabetes Care. 1998;  21 ((suppl. 2)) B161-B167
  • 12 ADA American Diabetes Association . Preconception care of women with diabetes: position statement.  Diabetes Care. 2001;  19 ((suppl. 1)) S25-S28
  • 13 Molsted-Pedersen L, Damm P. How to organize care for pregnant diabetic patients. In: Mogensen CE, Standl E, eds. concepts for the ideal diabets clinic. New York, Walter de Gruyter 1999: 199-214
  • 14 Giacchi M, Mattei M, Rossi S. Correction of the self-reported BMI in a teenage population.  Int J Obesity Relat Metab Disord. 1998;  22 673-677
  • 15 Kuczmarski MF, Kuczmarski RJ, Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988–1994.  J Amer Diet Associat. 2001;  101 28-34
  • 16 Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy . Am J Obstet Gynecol. 2000;  183 S1-S22
  • 17 Higgins JR, de Swiet M. Blood-pressure measurement and classification in pregnancy.  Lancet. 2001;  357 131-135
  • 18 Hypertension in Pregnancy. Guidelines on the detection, investigation and management of hypertension in pregnancy. See: http://www.health.nsw.gov.au/policies/
  • 19 Spranger J. et al . Errors of morphogenesis: concepts and terms. Recommendations of an International Working Group.  J Pediatr. 1982;  100 160-165
  • 20 Martinez-Frias ML, Frias JP, Bermejo E. et al . Pregestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes.  Diabetic Medicine. 2005;  22 ((6)) 775-781
  • 21 Homko CJ. et al . Is there a role for oral antyhyperglycemics in gestational diabetes and type 2 diabetes during pregnancy?.  Treat Endocrinol. 2004;  3 133-139
  • 22 Cundy T. et al . Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes.  Diabetic Medicine. 2002;  19 482-489
  • 23 Leinonen A. et al . Diurnal blood glucose profiles in women with gestational diabetes with or without hypertension.  Diabetic Medicine. 2004;  21 1181-1184
  • 24 Eckel RH. et al . The metabolic syndrome.  Lancet. 2005;  365 1415-1428
  • 25 Ruderman N. et al . The metabolically obese, normal-weight individual revisited.  Diabetes. 1998;  47 ((5)) 699-713
  • 26 Savona-Ventura C, Grima S. Hypertensive disorders during pregnancy in gestational diabetic women.  Exp Clin Endocrinol Diabetes. 2008;  116 ((6)) 329-332
  • 27 Xiao R. et al . Influence of pre-eclampsia on fetal growth.  J Matern Fetal Neonatal Med. 2003;  13 ((3)) 157-162
  • 28 Napoli A. et al . Twenty-four-hour blood pressure monitoring in normoalbuminuric normotensive type 1 diabetic women during pregnancy.  Journal Diabetes Complications. 2003;  17 292-296

Correspondence

A. NapoliMD 

Aggregate Professor of Endocrinology

Department of Clinical Sciences

S. Andrea Hospital

2nd Faculty of Medicine

‘Sapienza’ University

via di Grottarossa 1035–1039

00189 Rome

Italy

Phone: +39/06/33 77 53 35

Phone: +39/33/85 45 83 14

Fax: +39/06/33 77 57 40

Email: angela.napoli@uniroma1.it